Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSStandard

EPINEPHRINE

EPINEPHRINE

Standard Dose
30MG/30ML (1MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview EPINEPHRINE is listed in Drugs@FDA under application 219239 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 30MG/30ML (1MG/ML) Sponsor GLAND Submission history Latest submission status date: 2025-02-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview EPINEPHRINE is listed in Drugs@FDA under application 219239 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 30MG/30ML (1MG/ML) Sponsor GLAND Submission history Latest submission status date: 2025-02-06 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.